AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Set up an RSS feed
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Diabetes Week back issues
|
|
Sleep apnea occurring during REM sleep is significantly associated with type 2 diabetes.
June 29, 2009... A multi-ethnic study in the June 15 issue of the Journal of Clinical Sleep Medicine reports that there is a statistically significant relationship between obstructive sleep apnea (OSA) episodes occurring during rapid eye movement (REM) sleep and type 2 diabetes (see also American Academy of...
Aussie and Kiwi researchers make double MS genetic discovery.
June 29, 2009... Australian and New Zealand researchers have accelerated research into Multiple Sclerosis by discovering two new locations of genes which will help to unravel the causes of MS and other autoimmune disease (see also University of Melbourne).
Their findings will be published in the...
What is the relationship between hepatocellular carcinoma and type 2 diabetes mellitus?
June 29, 2009... Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide and the third leading cause of cancer-related deaths. Type 2 diabetes mellitus has been associated with HCC. However, the relationship between type 2 diabetes mellitus and the underlying liver cirrhosis, and the...
Research from R.A. Noel and co-authors reveals new findings on acute pancreatitis.(Report)
June 29, 2009... According to a study from the United States, "The objective of this study was to assess the risk of acute pancreatitis in patients with type 2 diabetes compared With that in patients without diabetes. We also examined the risk of biliary disease (defined as occurrence of cholelithiasis, acute...
New adverse drug reactions research from University of Pavia discussed.
June 29, 2009... According to recent research published in the Journal of Clinical Pharmacy and Therapeutics, "One of the problems associated with reaching the low-density lipoprotein cholesterol (LDL-C) target during statin treatment is the emergence of laboratory or clinical side effects. The aim of our...